Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sorting nexin 18 pseudogene 5 (SNX18P5) is classified as a pseudogene, according to the HUGO Gene Nomenclature Committee (HGNC ID: HGNC:39613). By definition, pseudogenes are DNA sequences that resemble known genes but are generally nonfunctional due to mutations preventing production of functional proteins. There is no evidence that SNX18P5 encodes a protein or serves as a molecular target, nor are biological functions, disease associations, or drug interactions known for this locus. SNX18P5 is distinct from "Sorting nexin 18" (SNX18), which is a protein-coding gene with known cellular functions. The entry is not a therapeutic target, receptor, enzyme, transporter, or similar. There is nothing to suggest SNX18P5 is functionally relevant, making it incorrect as a therapeutic target nomination.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sorting nexin 18 pseudogene 5 (SNX18P5).